Literature DB >> 27526281

Safety of repeated un-manipulated peripheral blood stem cell haploidentical transplant for graft failure.

H Aboul Nour1, N Patil2, J H Chewning3, A Di Stasi1, D Salzman1, R Innis-Shelton1, L Lamb1, S Mineishi4, A Saad1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27526281     DOI： 10.1038/bmt.2016.208

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.

Authors:  David A Rizzieri; Liang Piu Koh; Gwynn D Long; Cristina Gasparetto; Keith M Sullivan; Mitchell Horwitz; John Chute; Clayton Smith; Jerald Z Gong; Anand Lagoo; Donna Niedzwiecki; Jeannette M Dowell; Barbara Waters-Pick; CongXiao Liu; Dawn Marshall; James J Vredenburgh; Jon Gockerman; Carlos Decastro; Joseph Moore; Nelson J Chao
Journal:  J Clin Oncol       Date:  2007-01-16       Impact factor: 44.544

2.  Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.

Authors:  Nicoletta Cieri; Raffaella Greco; Lara Crucitti; Mara Morelli; Fabio Giglio; Giorgia Levati; Andrea Assanelli; Matteo G Carrabba; Laura Bellio; Raffaella Milani; Francesca Lorentino; Maria Teresa Lupo Stanghellini; Tiago De Freitas; Sarah Marktel; Massimo Bernardi; Consuelo Corti; Luca Vago; Chiara Bonini; Fabio Ciceri; Jacopo Peccatori
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-19       Impact factor: 5.742

3.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

Authors:  Claudio G Brunstein; Ephraim J Fuchs; Shelly L Carter; Chatchada Karanes; Luciano J Costa; Juan Wu; Steven M Devine; John R Wingard; Omar S Aljitawi; Corey S Cutler; Madan H Jagasia; Karen K Ballen; Mary Eapen; Paul V O'Donnell
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

4.  Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.

Authors:  A Bacigalupo; A Dominietto; A Ghiso; C Di Grazia; T Lamparelli; F Gualandi; S Bregante; M T Van Lint; S Geroldi; S Luchetti; R Grasso; S Pozzi; N Colombo; E Tedone; R Varaldo; A M Raiola
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

5.  A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing.

Authors:  Dolores Grosso; Matthew Carabasi; Joanne Filicko-O'Hara; Margaret Kasner; John L Wagner; Beth Colombe; Patricia Cornett Farley; William O'Hara; Phyllis Flomenberg; Maria Werner-Wasik; Janet Brunner; Bijoyesh Mookerjee; Terry Hyslop; Mark Weiss; Neal Flomenberg
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

6.  Second unrelated donor hematopoietic cell transplantation for primary graft failure.

Authors:  Jeffrey Schriber; Manza-A Agovi; Vincent Ho; Karen K Ballen; Andrea Bacigalupo; Hillard M Lazarus; Christopher N Bredeson; Vikas Gupta; Richard T Maziarz; Gregory A Hale; Mark R Litzow; Brent Logan; Martin Bornhauser; Roger H Giller; Luis Isola; David I Marks; J Douglas Rizzo; Marcelo C Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-19       Impact factor: 5.742

7.  Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.

Authors:  Scott R Solomon; Connie A Sizemore; Melissa Sanacore; Xu Zhang; Stacey Brown; H Kent Holland; Lawrence E Morris; Asad Bashey
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-19       Impact factor: 5.742

8.  HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.

Authors:  Junichi Sugita; Naomi Kawashima; Tomoaki Fujisaki; Kazuhiko Kakihana; Shuichi Ota; Keitaro Matsuo; Toshihiro Miyamoto; Koichi Akashi; Shuichi Taniguchi; Mine Harada; Takanori Teshima
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-18       Impact factor: 5.742

9.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

10.  Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure.

Authors:  Takayoshi Tachibana; Eri Yamamoto; Rika Kawasaki; Hideyuki Koharazawa; Daisuke Ishibashi; Yuki Nakajima; Masatsugu Tanaka; Kenji Matsumoto; Yoshiaki Ishigatsubo; Shin Fujisawa
Journal:  Intern Med       Date:  2015-11-01       Impact factor: 1.271
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.